Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C

Table 3 Level of GF in chronic hepatitis C during IFNα2b with RBV therapy (mean±SD).

	HGF (pg/mL)	EGF (pg/mL)	TPO (pg/mL)	PDGF (pg/mL)
Healthy	748±91	12.9±3.3	47.6±16.5	473.2±145
0 (I)	983±227	18.4±7.1a	55.5±17.2	387±116
16 wk (II)	752±277	12.7±6.3	71±56.3	334±84.8a
32 wk (III)	783±297	13.9±5.2	67.5±18.3a	342±84.5a
48 wk (IV)	770±278	15.8±5.7	62.5±28.1	330±138a
P value	NS	I:II P<0.01	NS	I:II P<0.02
		I:III P<0.01		I:III P<0.03
		II:IV P<0.04

^aP<0.05 Student’s t test.